Bank of New York Mellon’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,635
| Closed | -$25K | – | 4598 |
|
|
2022
Q3 | $25K | Hold |
3,635
| – | – | ﹤0.01% | 4421 |
|
|
2022
Q2 | $39K | Sell |
3,635
-22
| -0.6% | -$236 | ﹤0.01% | 4395 |
|
|
2022
Q1 | $82K | Hold |
3,657
| – | – | ﹤0.01% | 4441 |
|
|
2021
Q4 | $103K | Buy |
3,657
+1,754
| +92% | +$49.4K | ﹤0.01% | 4397 |
|
|
2021
Q3 | $124K | Buy |
1,903
+1,605
| +539% | +$105K | ﹤0.01% | 4284 |
|
|
2021
Q2 | $24K | Sell |
298
-1,484
| -83% | -$120K | ﹤0.01% | 4374 |
|
|
2021
Q1 | $237K | Sell |
1,782
-7
| -0.4% | -$931 | ﹤0.01% | 3998 |
|
|
2020
Q4 | $285K | Sell |
1,789
-85
| -5% | -$13.5K | ﹤0.01% | 3849 |
|
|
2020
Q3 | $197K | Buy |
1,874
+253
| +16% | +$26.6K | ﹤0.01% | 3852 |
|
|
2020
Q2 | $196K | Sell |
1,621
-95
| -6% | -$11.5K | ﹤0.01% | 3801 |
|
|
2020
Q1 | $134K | Hold |
1,716
| – | – | ﹤0.01% | 3821 |
|
|
2019
Q4 | $505K | Buy |
1,716
+111
| +7% | +$32.7K | ﹤0.01% | 3592 |
|
|
2019
Q3 | $290K | Buy |
1,605
+41
| +3% | +$7.41K | ﹤0.01% | 3785 |
|
|
2019
Q2 | $624K | Sell |
1,564
-186
| -11% | -$74.2K | ﹤0.01% | 3492 |
|
|
2019
Q1 | $818K | Buy |
1,750
+72
| +4% | +$33.7K | ﹤0.01% | 3301 |
|
|
2018
Q4 | $806K | Buy |
1,678
+95
| +6% | +$45.6K | ﹤0.01% | 3225 |
|
|
2018
Q3 | $1.08M | Buy |
1,583
+63
| +4% | +$42.9K | ﹤0.01% | 3218 |
|
|
2018
Q2 | $1.04M | Buy |
+1,520
| New | +$1.04M | ﹤0.01% | 3222 |
|